'International Congress on Targeted Anticancer Therapies', Paris, France
4 March 2013 - 4 March 2013
France
An event entitled 'International Congress on Targeted Anticancer Therapies (TAT 2013)' will take from 4 to 6 March 2013 in Paris, France.
Targeted cancer therapies are drugs or other substances that block the growth and spread of cancer by interfering with specific molecules involved in tumour growth and progression. Because scientists often call these molecules 'molecular targets', targeted cancer therapies are sometimes called 'molecularly targeted drugs' or 'molecularly targeted therapies'. By focusing on molecular and cellular changes that are specific to cancer, targeted cancer therapies may be more effective than other types of treatment, including chemotherapy and radiotherapy, and less harmful to normal cells.
On the other hand, the treatment raises new questions related to the tailoring of cancer treatment to an individual patient's tumour, the assessment of drug effectiveness and toxicity, and the economics of cancer care.
The conference will be a forum for the scientific community to exchange on clinical and translational research, as well as promising new molecularly targeted cancer therapeutics.For further information, please visit
http://www.tatcongress.org/tat13-home.html(opens in new window)
Targeted cancer therapies are drugs or other substances that block the growth and spread of cancer by interfering with specific molecules involved in tumour growth and progression. Because scientists often call these molecules 'molecular targets', targeted cancer therapies are sometimes called 'molecularly targeted drugs' or 'molecularly targeted therapies'. By focusing on molecular and cellular changes that are specific to cancer, targeted cancer therapies may be more effective than other types of treatment, including chemotherapy and radiotherapy, and less harmful to normal cells.
On the other hand, the treatment raises new questions related to the tailoring of cancer treatment to an individual patient's tumour, the assessment of drug effectiveness and toxicity, and the economics of cancer care.
The conference will be a forum for the scientific community to exchange on clinical and translational research, as well as promising new molecularly targeted cancer therapeutics.For further information, please visit
http://www.tatcongress.org/tat13-home.html(opens in new window)